References
- Beutler, E., Nguyen, N.J., Henneberger, M.W., Smolec, J.M., McPherson, R.A., West, C. and Gelbart, T. (1993) "Gaucher disease: gene frequencies in the Ashkenazi Jewish popu-lation", Am. J. Hum. Genet. 52, 85–88.
- Hollak, CE., Corssmit, E.P., Aerts, J.M., Endert, E., Sauerwein, H.P., Romijn, J.A. and van Oers, M.H. (1997) "Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease", Am. J. Med. 103, 185–191.
- Allen, M.J., Myer, B.J., Khokher, N., Rushton, N. and Cox, T.M. (1997) "Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10", Q.J.M. 90, 19–25.
- Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J.S., Humphries, S. and Woo, P. (1998) "The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis", J. Clin. Investig. 102, 1369–1376.
- Fernandez-Real, J.M., Vendrell, J., Richart, C., Gutierrez, C. and Ricart, W. (2001) "Platelet counts and interleukin 6 gene polymorphism in healthy subjects", BMC Med. Genet. 2, 6.
- Weinreb, N.J., Charrow, J., Andersson, H.C., Kaplan, P., Kolodny, E.H., Mistry, P., Pastores, G., Rosenbloom, BE., Scott, CR., Wappner, R.S. and Zimran, A. (2002) "Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry", Am. J. Med. 113, 112–119.
- Altarescu, G., Philips, M., Foldes, J., Elstein, D., Zimran, A. and Mates, M. (2003) "Interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher disease: a new modifier gene?", Q.J.M. (in press).